Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4/A Registration of securities issued in business combination transactions
- 2.2 Side Letter to Business Combination Agreement, Dated November 32, 2022, by and Among Larkspur Health Acquisition Corp., Larkspur Merger Sub Inc., Stephen Glover and Zyversa Therapeutics, Inc
- 3.6 Form of Certificate of Designation of Larkspur Health Acquisition Corp. Relating to the Series B Convertible Preferred Stock
- 5.1 Opinion of Alston & Bird LLP As to the Validity of the Shares of Common Stock and Warrants
- 8.1 Tax Opinion of Lowenstein Sandler LLP
- 10.19 Form of Amendment #1 to the Securities Purchase Agreement, by and Among Larkspur Health Acquisition Corp. and Each Purchaser Identified on the Signature Pages Thereto
- 23.1 Consent of Marcum LLP, Independent Registered Public Accounting Firm of Larkspur Health Acquisition Corp
- 23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Zyversa Therapeutics, Inc
- 99.6 Consent of Cassel Salpeter & Co., LLC
- EX-FILING FEES Filing Fee Table
- Download Excel data file
- View Excel data file
Associated filings
- 15 Nov 22 EFFECT Notice of effectiveness
- 14 Nov 22 424B3 Prospectus supplement
-
3 Nov 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 20 Oct 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 27 Sep 22 S-4/A Registration of securities issued in business combination transactions (amended)
- 12 Aug 22 S-4 Registration of securities issued in business combination transactions
ZVSA similar filings
Filing view
External links